Marvell Technology's stock soared 5.07% during Tuesday's intraday session, extending a significant rebound for the semiconductor company.
The sharp move higher follows a series of bullish analyst actions. UBS significantly raised its price target on Marvell to $340 from $230 while maintaining a Buy rating, citing strong long-term growth prospects for the company's Compute Express Link (CXL) chip business. The firm projects CXL-related revenue could reach $20 billion by 2028. Bank of America Securities also raised its target to $365 from $240, and Stifel lifted its target to $350 from $321.
The upgrades reflect growing optimism about Marvell's positioning within the AI infrastructure buildout. As hyperscalers design custom chips to run more efficient and cost-effective AI inference workloads, companies like Marvell that supply this custom silicon are seen as key beneficiaries. This trend is part of a broader shift toward "agentic AI," where continuous AI workflows consume significantly more computing resources than single-shot queries, driving demand across the semiconductor infrastructure stack.
Comments